首页|含查尔酮片段的HDAC6抑制剂的设计、合成和抗癌活性评价

含查尔酮片段的HDAC6抑制剂的设计、合成和抗癌活性评价

扫码查看
查尔酮具有抗癌、抗炎和抗氧化等多种生物活性,组蛋白去乙酰化酶6(HDAC6)是一个重要的抗癌靶点.利用分子杂合原理,设计、合成了5个含查尔酮片段结构的HDAC6抑制剂,并在体外评价了抑制剂对胃癌细胞和HDAC6蛋白抑制活性.结果表明,目标化合物对胃癌细胞HGC27和MGC803具有较强的抑制活性,IC50值在1.0-7.4 μM之间;体外对HDAC6蛋白也具有较强的抑制活性,IC50值在4.6~47.8 nM之间.其中化合物17对胃癌细胞的细胞毒性最强,与HDAC6蛋白亲和力也最强,分子对接也证实了这一结果.因此,含查尔酮片段结构的HDAC6抑制剂值得进一步研究.
Design,Synthesis and Anticancer Activity Evaluation of HDAC6 Inhibitors Containing Chalcone Fragments
Chalcone has various biological activities such as anti-cancer,anti-inflammatory,and antioxidant.Histone deacetylase 6(HDAC6)is an important anti-cancer target.According to the principle of molecular hybridization,5 HDAC6 inhibitors containing chalcone fragment were designed and synthesized,and evaluated anticancer activity against gastric cancer cells and inhibition of HDAC6 protein in vitro.The results showed that the target compounds had strong inhibition against gastric cancer cells HGC27 and MGC803,with IC50 values ranging from 1.0 to 7.4 pM.They also exhibited strong inhibition against HDAC6 protein in vitro,with an IC50 value ranging from 4.6 to 47.8 nM.Among them,compound 17 had the strongest cytotoxicity against gastric cancer cells HGC27 and MGC803,and also exhibited the strongest affinity with HDAC6 protein.Molecular docking also confirmed the results.These results indicate that HDAC6 inhibitors containing chalcone structures are worth further investigation.

chalconemolecular dockingHDAC6 inhibitoranticancer activity

喻明军、程楠、张小倩、李鑫鑫、李慧

展开 >

亳州学院中药学院,安徽亳州 236800

查尔酮 分子对接 HDAC6抑制剂 抗癌活性

2024

韶关学院学报
韶关学院

韶关学院学报

影响因子:0.28
ISSN:1007-5348
年,卷(期):2024.45(9)